Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


14.01.2019

1 BMC Neurol
1 J Neuroimmunol
1 J Neurol
3 Mult Scler
1 Nat Rev Neurol
4 Neurology
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. SAIDA T, Yamamura T, Kondo T, Yun J, et al
    A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries.
    BMC Neurol. 2019;19:5.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  2. ARAMIDEH KHOUY R, Karampoor S, Keyvani H, Bokharaei-Salim F, et al
    The frequency of varicella-zoster virus infection in patients with multiple sclerosis receiving fingolimod.
    J Neuroimmunol. 2018;328:94-97.
    PubMed     Text format     Abstract available


    J Neurol

  3. HARTUNG HP, Graf J, Kremer D
    Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study.
    J Neurol. 2019 Jan 4. pii: 10.1007/s00415-018-09169.
    PubMed     Text format     Abstract available


    Mult Scler

  4. FUCHS TA, Wojcik C, Wilding GE, Pol J, et al
    Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis.
    Mult Scler. 2019 Jan 7:1352458518820272. doi: 10.1177/1352458518820272.
    PubMed     Text format     Abstract available

  5. JAKIMOVSKI D, Benedict RH, Marr K, Gandhi S, et al
    Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients.
    Mult Scler. 2019 Jan 9:1352458518819608. doi: 10.1177/1352458518819608.
    PubMed     Text format     Abstract available

  6. PAGANI E, Rocca MA, De Meo E, Horsfield MA, et al
    Structural connectivity in multiple sclerosis and modeling of disconnection.
    Mult Scler. 2019 Jan 9:1352458518820759. doi: 10.1177/1352458518820759.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  7. ROCCA MA, Filippi M
    Targeting progression in multiple sclerosis - an update.
    Nat Rev Neurol. 2019 Jan 4. pii: 10.1038/s41582-018-0127.
    PubMed     Text format    


    Neurology


  8. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2019;92:112.
    PubMed     Text format    

  9. RAE-GRANT A
    Author response: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2019;92:110-111.
    PubMed     Text format    

  10. SALTONSTALL L
    Reader response: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2019;92:109-110.
    PubMed     Text format    

  11. LEWIS A, Galetta S
    Editors' note: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2019;92:109.
    PubMed     Text format    


    Rev Neurol (Paris)

  12. CAVALLIERI F, Godeiro C, Lino JC Jr, Moro E, et al
    Cervical dystonia in a case of longstanding secondary progressive multiple sclerosis.
    Rev Neurol (Paris). 2019 Jan 3. pii: S0035-3787(18)30500.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: